ADAM9 and lung adenocarcinoma: Although several reports have documented that up-regulation of CDCP1 expression was associated with disease progression in different human tumor types20, our data are the first study to report that CDCP1 is regulated by miR-218, and hence provide a novel regulatory mechanism of miR-218 involved in the ADAM9-CDCP1 axis in lung adenocarcinoma.